معرفی
Dr. Natasha Krishnadas is an Adjunct Senior Lecturer in the School of Clinical Sciences at Monash University and a Neurologist with specialized training in Cognitive Neurology. She is actively involved in clinical research on Alzheimer’s disease and related dementias, contributing to both neuroimaging and biomarker validation studies. Her affiliations include Monash Health and the Eastern Clinical Research Unit, where she serves as a Casual Research Assistant.
- PhD in Neuroscience – University of Melbourne (2022)
- MBBS in Medicine – Australian National University (2012)
- BBNSc in Behavioural Neuroscience – Monash University (2008)
Her primary research interests include Alzheimer's disease, dementia and cognitive impairment, tau and amyloid PET imaging, blood-based biomarkers, and the long-term consequences of traumatic brain injury. She has made significant contributions to understanding the role of toxic proteins in neurodegeneration and their clinical implications.
Her recent publications reflect a strong focus on biomarker development and validation, particularly plasma pTau217 and neuroimaging standardization (e.g., CenTauR). Her work spans high-impact journals such as Brain, EBioMedicine, and Alzheimer's and Dementia, demonstrating a trend toward translational neuroscience and early diagnostic innovation.
- Craig Drummond PhD Award (2023)
- Human Amyloid Imaging Conference Young Investigator Travel award (2023)
- Victorian Biomedical Imaging Capability (VBIC) Early Career Researcher award (2022)
Dr. Krishnadas has been actively involved in collaborative research projects and clinical trials, often working with large consortia such as the Alzheimer's Disease Neuroimaging Initiative and the AIBL research group. While no formal students are listed, her role as a sub-investigator and co-author on numerous studies indicates mentorship and team leadership in research settings. She has also contributed to projects validating blood biomarkers for Alzheimer’s disease, supported by national and international collaborations.
Her research is conducted within multidisciplinary teams focused on neurodegenerative diseases, integrating clinical neurology, advanced imaging, and biomarker science. These teams include experts in PET imaging, neurology, psychiatry, and data science, particularly through her work at Monash Health and affiliations with major research initiatives.
